Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 4/20 | 0.64 |
| ▸ | NMUR1 | Q9HB89 | 4/20 | 0.64 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.64 |
| ▸ | TFPI | P10646 | 4/20 | 0.63 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.63 |
| ▸ | NPY2R | P49146 | 6/20 | 0.60 |
| ▸ | NPY4R | P50391 | 6/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.60 |
| ▸ | NPY1R | P25929 | 4/20 | 0.60 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.59 |
| ▸ | CALCR | P30988 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31707403 | 0.97 | CXCR4 (0.62) | NMUR2NMUR1CXCR4TFPIEPHA2 | |
| SCHEMBL31012332 | 0.96 | TFPI (0.63) | NMUR2NMUR1CXCR4TFPINPY2R | |
| SCHEMBL32670411 | 0.92 | EPHA2 (0.68) | NMUR2NMUR1TFPIEPHA2NPY2R | |
| SCHEMBL30335928 | 0.91 | EPHA2 (0.68) | NMUR2NMUR1TFPIEPHA2NPY2R | |
| SCHEMBL30327403 | 0.91 | EPHA2 (0.68) | NMUR2NMUR1TFPIEPHA2NPY2R | |
| SCHEMBL31182912 | 0.91 | NPY2R (0.66) | NMUR2NMUR1TFPINPY2RNPY4R | |
| SCHEMBL29562124 | 0.90 | NPY2R (0.67) | NMUR2NMUR1TFPINPY2RNPY4R | |
| SCHEMBL30495721 | 0.90 | NPY2R (0.65) | CXCR4TFPINPY2RNPY4RNPY5R | |
| SCHEMBL29632841 | 0.90 | TFPI (0.64) | NMUR2NMUR1TFPIEPHA2NPY2R | |
| SCHEMBL31182566 | 0.90 | TFPI (0.68) | CXCR4TFPINPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4415744-A1 | PEPTIDES AND FRAGMENTS FOR TREATING DIABETES AND ASSOCIATED METABOLIC DISEASES | Betavive Ltd. (IL) | 2024-08-21 | — | — | EP | disclosed |
| WO-2023062545-A1 | PEPTIDES AND FRAGMENTS FOR TREATING DIABETES AND ASSOCIATED METABOLIC DISEASES | BETAVIVE LTD. (IL) | 2023-04-20 | — | — | WO | disclosed |